{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:54:52Z","timestamp":1791618892331,"version":"4.3.4"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["20R90174"],"award-info":[{"award-number":["20R90174"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,15]]},"DOI":"10.1093\/hmg\/ddx394","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T15:11:43Z","timestamp":1509981103000},"page":"239-253","source":"Crossref","is-referenced-by-count":36,"title":["HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo"],"prefix":"10.1093","volume":"27","author":[{"given":"Dagmar E","family":"Ehrnhoefer","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L","family":"Southwell","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenalochani","family":"Sivasubramanian","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyun","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Waltl","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Fazeli","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Casal","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Felczak","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Tsang","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Hayden","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, University of British Columbia, Vancouver, BC V5Z 4H4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"key":"key\n\t\t\t\t20180328140415_ddx394-B1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11010-013-1951-9","article-title":"A mitochondrial basis for Huntington\u2019s disease: therapeutic prospects","volume":"389","author":"Chakraborty","year":"2014","journal-title":"Mol. Cell. Biochem"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington\u2019s disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.drudis.2014.02.006","article-title":"Mechanisms of synaptic dysfunction and excitotoxicity in Huntington\u2019s disease","volume":"19","author":"Sepers","year":"2014","journal-title":"Drug Discov. Today"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/hmg\/dds516","article-title":"Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington\u2019s disease","volume":"22","author":"Valencia","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","article-title":"Huntington\u2019s disease","volume":"220","author":"Zuccato","year":"2014","journal-title":"Handb. Exp. Pharmacol"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B9","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","article-title":"The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation","volume":"34","author":"Wong","year":"2014","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B12","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","article-title":"Oxidative stress parameters in plasma of Huntington\u2019s disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects: a cross-sectional study","volume":"254","author":"Klepac","year":"2007","journal-title":"J. Neurol"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B14","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B15","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1073\/pnas.1314421111","article-title":"hace1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response","volume":"111","author":"Rotblat","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B16","doi-asserted-by":"crossref","first-page":"re3.","DOI":"10.1126\/scisignal.3112re3","article-title":"Stress-activated cap\u2019n\u2019collar transcription factors in aging and human disease","volume":"3","author":"Sykiotis","year":"2010","journal-title":"Sci. Signal"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/rej.2015.1736","article-title":"Time-course analysis of protein and lipid oxidation in the brains of Yac128 Huntington\u2019s disease transgenic mice","volume":"19","author":"Brocardo","year":"2016","journal-title":"Rejuvenation Res"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","article-title":"Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases","volume":"1842","author":"Gan","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B21","doi-asserted-by":"crossref","first-page":"7066.","DOI":"10.1038\/ncomms8066","article-title":"Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2","volume":"6","author":"Bell","year":"2015","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B22","doi-asserted-by":"crossref","first-page":"24200.","DOI":"10.1038\/srep24200","article-title":"Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: implications for mitochondrial ferritin","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/toxsci\/kfi027","article-title":"Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells","volume":"83","author":"Li","year":"2005","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.04.036","article-title":"The emerging role of Nrf2 in mitochondrial function","volume":"88","author":"Dinkova-Kostova","year":"2015","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/B978-0-12-801415-8.00016-3","article-title":"Analysis and interpretation of microplate-based oxygen consumption and pH data","volume":"547","author":"Divakaruni","year":"2014","journal-title":"Methods Enzymol"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/bio.20134853","article-title":"Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration","volume":"2","author":"Holmstrom","year":"2013","journal-title":"Biol. Open"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B28","doi-asserted-by":"crossref","first-page":"e0132263.","DOI":"10.1371\/journal.pone.0132263","article-title":"The role of intermittent hypoxia on the proliferative inhibition of rat cerebellar astrocytes","volume":"10","author":"Chiu","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B29","doi-asserted-by":"crossref","first-page":"5.","DOI":"10.1186\/s13041-016-0186-6","article-title":"PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes","volume":"9","author":"Choi","year":"2016","journal-title":"Mol. Brain"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/glia.22475","article-title":"PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR","volume":"61","author":"Choi","year":"2013","journal-title":"Glia"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7854_2013_238","article-title":"Clinical Aspects of Huntington's Disease","volume-title":"Behavioural Neurobiology of Huntington's Disease and Parkinson's Disease, Current Topics in Behavioral Neurosciences 22","author":"Ghosh","year":"2013"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B32","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B33","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","article-title":"Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease","volume":"76","author":"Southwell","year":"2015","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B36","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainresbull.2011.05.005","article-title":"Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington\u2019s disease transgenic mice","volume":"88","author":"Bayram-Weston","year":"2012","journal-title":"Brain Res. Bull"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B40","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1073\/pnas.94.8.4103","article-title":"Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches","volume":"94","author":"Schauwecker","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2011.03.002","article-title":"Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB\/N mice","volume":"43","author":"Gogliotti","year":"2011","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B42","first-page":"34","article-title":"Neuropathologic findings associated with seizures in FVB mice","volume":"48","author":"Goelz","year":"1998","journal-title":"Lab. Anim. Sci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0896-6273(95)90107-8","article-title":"Age-related CNS disorder and early death in transgenic FVB\/N mice overexpressing Alzheimer amyloid precursor proteins","volume":"15","author":"Hsiao","year":"1995","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0197-4580(93)90100-P","article-title":"GFAP mRNA increases with age in rat and human brain","volume":"14","author":"Nichols","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0197-4580(91)90056-P","article-title":"Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain","volume":"12","author":"Goss","year":"1991","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B46","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2353\/ajpath.2007.060898","article-title":"Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2","volume":"170","author":"Hubbs","year":"2007","journal-title":"Am. J. Pathol"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B47","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/ng.2732","article-title":"Glutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease","volume":"45","author":"Mason","year":"2013","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B49","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington\u2019s disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B51","doi-asserted-by":"crossref","first-page":"10.","DOI":"10.1186\/1750-1326-4-10","article-title":"PGC-1alpha as modifier of onset age in Huntington disease","volume":"4","author":"Taherzadeh-Fard","year":"2009","journal-title":"Mol. Neurodegener"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B52","doi-asserted-by":"crossref","first-page":"142ra197.","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1alpha rescues Huntington\u2019s disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B54","doi-asserted-by":"crossref","first-page":"3.","DOI":"10.1186\/1750-1326-4-3","article-title":"The gene coding for PGC-1alpha modifies age at onset in Huntington\u2019s disease","volume":"4","author":"Weydt","year":"2009","journal-title":"Mol. Neurodegener"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B56","doi-asserted-by":"crossref","first-page":"e10025.","DOI":"10.1371\/journal.pone.0010025","article-title":"PGC-1alpha down-regulation affects the antioxidant response in Friedreich\u2019s ataxia","volume":"5","author":"Marmolino","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B57","doi-asserted-by":"crossref","first-page":"e16172.","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington\u2019s disease","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington\u2019s disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1073\/pnas.0408487101","article-title":"Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription","volume":"102","author":"Calkins","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B60","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2014.110","article-title":"Impaired brain energy metabolism in the BACHD mouse model of Huntington\u2019s disease: critical role of astrocyte-neuron interactions","volume":"34","author":"Boussicault","year":"2014","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B61","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nbd.2013.06.002","article-title":"Enhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington\u2019s disease mouse model","volume":"58","author":"Lee","year":"2013","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B62","doi-asserted-by":"crossref","first-page":"11758.","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B63","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1523\/JNEUROSCI.21-17-06480.2001","article-title":"Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity","volume":"21","author":"Bal-Price","year":"2001","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/dmm.002451","article-title":"Mouse models of Huntington disease: variations on a theme","volume":"2","author":"Ehrnhoefer","year":"2009","journal-title":"Dis. Model. Mech"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B65","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm1621","article-title":"The E3 ligase hace1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers","volume":"13","author":"Zhang","year":"2007","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B66","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","article-title":"Wild-type huntingtin protects neurons from excitotoxicity","volume":"96","author":"Leavitt","year":"2006","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B67","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B68","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1523\/JNEUROSCI.1589-10.2010","article-title":"Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A","volume":"30","author":"Metzler","year":"2010","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B70","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/hmg\/5.12.1875","article-title":"Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype","volume":"5","author":"Hodgson","year":"1996","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B71","doi-asserted-by":"crossref","first-page":"e107434.","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients","volume":"9","author":"Skotte","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","article-title":"A fully humanized transgenic mouse model of Huntington disease","volume":"22","author":"Southwell","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328140415_ddx394-B73","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol. Ther"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/27\/2\/239\/24325598\/ddx394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T14:12:57Z","timestamp":1570284777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/27\/2\/239\/4600049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,11,7]]},"published-print":{"date-parts":[[2018,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx394","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,15]]},"published":{"date-parts":[[2017,11,7]]}}}